Skip to content

13F-HR filed by Atalan Capital Partners, LP

Atalan Capital Partners, LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 11 holding rows worth $1,302,101,634.

Accession
0000919574-25-004856
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 11 entries on the cover page, a total value of $1,302,101,634 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,302,101,634 with VALUE read as dollars as filed, 13F file number 028-17286. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
S&P Global,Inc.78409V104COM300,000$158,187,000dollars as filed
AMPHENOL CORP NEW032095101COM1,600,000$158,000,000dollars as filed
US FOODS HLDG CORP COM912008109Stock2,025,000$155,945,250dollars as filed
WILLIS TOWERS WATSON PLC LTD SHSG96629103Stock500,000$153,250,000dollars as filed
TALEN ENERGY CORP COM87422Q109Stock510,000$148,292,700dollars as filed
TRANSDIGM GROUP INC COM893641100Stock90,000$136,857,600dollars as filed
MasterCard, Inc57636Q104COM235,000$132,055,900dollars as filed
HEALTHEQUITY INC COM42226A107Stock700,000$73,332,000dollars as filed
SEAGATE TECHNOLOGY HLDNGSG7997R103ORD SHS500,000$72,165,000dollars as filed
WESTERN DIGITAL CORP958102105COM1,084,788$69,415,584dollars as filed
Thermo Fisher Scientific Inc.883556102COM110,000$44,600,600dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-25-004856this filing2025-08-14acceptance time not in the bulk data set